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Key points
 Patients with diabetes show a blunted cardiac inotropic response to β-adrenergic stimulation
despite normal cardiac contractile reserve.
 Acute insulin stimulation impairs β-adrenergically induced contractile function in isolated
cardiomyocytes and Langendorff-perfused hearts.
 In this study, we aimed to examine the potential effects of hyperinsulinaemia associated with
high-fat diet (HFD) feeding on the cardiac β2-adrenergic receptor signalling and the impacts
on cardiac contractile function.
 We showed that 8 weeks of HFD feeding leads to reductions in cardiac functional
reserve in response to β-adrenergic stimulation without significant alteration of cardiac
structure and function, which is associated with significant changes in β2-adrenergic receptor
phosphorylation at protein kinase A and G-protein receptor kinase sites in the myocardium.
 The results suggest that clinical intervention might be applied to subjects in early diabetes
without cardiac symptoms to prevent further cardiac complications.
Abstract Patients with diabetes display reduced exercise capability and impaired cardiac contra-
ctile reserve in response to adrenergic stimulation. We have recently uncovered an insulin
receptor and adrenergic receptor signal network in the heart. The aim of this study was to
understand the impacts of high-fat diet (HFD) on the insulin–adrenergic receptor signal network
in hearts. After 8 weeks ofHFD feeding,mice exhibited diabetes, with elevated insulin and glucose
concentrations associated with body weight gain. Mice fed an HFD had normal cardiac structure
and function. However, the HFD-fed mice displayed a significant elevation of phosphorylation
of the β2-adrenergic receptor (β2AR) at both the protein kinase A site serine 261/262 and the
G-protein-coupled receptor kinase site serine 355/356 and impaired adrenergic reserve when
compared with mice fed on normal chow. Isolated myocytes from HFD-fed mice also displayed
a reduced contractile response to adrenergic stimulation when compared with those of control
mice fed normal chow. Genetic deletion of the β2AR led to a normalized adrenergic response and
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preserved cardiac contractile reserve in HFD-fed mice. Together, these data indicate that HFD
promotes phosphorylation of the β2AR, contributing to impairment of cardiac contractile reserve
before cardiac structural and functional remodelling, suggesting that early intervention in the
insulin–adrenergic signalling network might be effective in prevention of cardiac complications
in diabetes.
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Introduction
Population-based studies have shown that patients with
type 2 diabetes have two to three times the risk of
heart disease when compared with the general population
(Bell, 2003; From et al. 2006). The increased incidence
of heart failure in diabetic patients persists despite
correction for age, hypertension, hypercholesterolaemia
and coronary artery disease (Boudina & Abel, 2007). The
pathogenesis of diabetic cardiomyopathy is multifactorial.
Several hypotheses have been proposed, including
metabolic derangements, abnormalities in ion homeo-
stasis, alteration in structural proteins and interstitial
fibrosis (Boudina & Abel, 2007). One of the hallmarks
in type 2 diabetes is insulin resistance and the associated
increase in the concentrations of circulating insulin, free
fatty acids and glucose, which are risk factors for diabetic
cardiomyopathy (Fang et al. 2004). Many studies have
documented the effects of fatty acids and glucose in the
myocardium, including dysregulation of metabolism and
autophagy and an increase in oxidative stress (Ansley &
Wang, 2013; Kubli & Gustafsson, 2014). These alterations
not only contribute to cardiac contractile dysfunction, but
also promote cardiac remodelling and increase the risk of
cardiac ischaemic events (Ansley &Wang, 2013; Mei et al.
2015). In contrast, little is known about the impacts of
circulating insulin on diabetic hearts.
The prominent defect in diabetic hearts is diastolic
dysfunction, with preservation of the ejection fraction
(EF; Desai & Fang, 2008). A large number of diabetic
patients also show a decrease in exercise tolerance before
the onset of overt cardiac dysfunction (Scognamiglio et al.
1995), which has been attributed to autonomic neuro-
pathy (Vinik & Ziegler, 2007). Others have reported that
exercise-intolerant patients also show a blunted inotropic
response to dobutamine stimulation, suggesting that the
cardiac β-adrenergic system is affected (Scognamiglio
et al. 1995). In agreement, cardiac preparations from
streptozotocin-induced diabetic rats display reduced
inotropic and chronotropic responses to β-adrenergic
stimulation (Vadlamudi & McNeill, 1984; Yu & McNeill,
1991). These studies suggest that exercise intolerance and
a blunted inotropic response to adrenergic stimulation
can be considered as early signs of diabetic cardio-
myopathy, preceeding clinical symptoms of cardiac
complications.Mechanistically, in streptozotocin-induced
diabetic rats, the expression of cardiac β1-adrenergic
receptors (β1ARs) is significantly decreased, which
may account for the depressed contractile response to
adrenergic stimuli (Heyliger et al. 1982). Meanwhile, in
leptin receptor-deficient db/db mice, an impaired cardiac
functional reserve capacity during maximal β-adrenergic
stimulation is linkedwith unfavourable changes in cardiac
energy metabolism (Daniels et al. 2010). Therefore, the
mechanisms involved in the early stages of myocardial
adaptations, such as exercise intolerance and a blunted
inotropic response to adrenergic stimulation, prior to
an overt decline in mechanical performance, are still
incompletely understood.
β-Adrenergic signalling is essential in the regulation of
cardiac function in response to stress. Both β1ARs and
β2-adrenergic receptors (β2ARs) are functionally coupled
to the adenylate cyclase system, contributing to the cardiac
response to β-adrenergic stimulation (Dincer et al. 2001).
In congestive and ischaemic human heart failure, elevated
sympathetic drive can promote compensatory cardiac
contractility. But chronic sympathetic stress leads to
desensitizationofβARsvia severalmolecularmechanisms,
including a decrease in the expression of β1ARs and in
coupling of β1ARs to adenylate cyclase, and an increase in
the expression of inhibitory G-protein (Gi) and G-protein
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
J Physiol 595.6 High-fat diet induces β2-adrenergic receptor phosphorylation 1975
receptor kinases (GRKs; Liggett, 2001). The cardiac β2AR
signalling is traditionally considered beneficial to the
myocardium relative to the cardiac toxicity induced
by β1ARs (Bernstein et al. 2005; Grundy, 2015).
Phosphorylated β2ARs couple to Gi and promote Akt
signalling (Wang et al. 2008), which protects myo-
cytes against apoptosis induced by oxidative stress or
chronic sympathetic β1AR signalling (Zhu et al. 2001).
However, the same β2AR–Gi coupling can lead to
inhibition of adenylate cyclase, which compromises cAMP
and protein kinase A (PKA) activity and contributes
to cardiac dysfunction in pressure-overload transaortic
constrictionmodels (Du et al. 2000; Zhu et al. 2012). Taken
together, these previous findings suggest that changes
in β-adrenergic signalling in the heart may play either
a detrimental or a protective role depending on the
pathological setting.
We have recently characterized a complex consisting
of the insulin receptor (IR) and the β2AR in the heart
(Fu et al. 2014). Furthermore, acute insulin stimulation
promotes cross-talk with the β2AR signalling pathway in a
Gβγ-independent, insulin receptor substrate-dependent
G-protein receptor kinase (GRK)2 phosphorylation of
β2ARs. Consequently, insulin impairs β-adrenergically
induced contractile function in isolated cardiomyocytes
and in Langendorff-perfused hearts (Fu et al. 2014). In
the present study, we aimed to examine the potential
effects of hyperinsulinaemia associated with feeding a
high-fat diet (HFD) on the cardiac IR–β2AR signalling
network and the impacts on cardiac adaptation during
early stages of diabetes.Mice lacking theβ2AR (β2AR-KO)
were used to define whether the β2AR is a contributor to
hyperinsulinaemia-induced βAR signalling dysfunction.
We analysed cardiac function at the baseline and after
β-adrenergic stimulation by I.P. injection of isoproterenol
after 8 weeks of HFD feeding. Cardiac structural
remodelling was analysed using immunohistochemical
and biochemical analyses. Our results show that
8 weeks of HFD feeding leads to decreases in cardiac
functional reserve in response to β-adrenergic stimulation
without significant alteration of cardiac structure and
basal function. This decrease in cardiac functional reserve
is associated with significant increases in the levels of
phosphorylation of the β2AR at PKA and GRK sites in
the heart.
Methods
Ethical approval
The animal care and experimental protocols conform
to the principles of UK regulations (Grundy, 2015)
and were approved by the institutional animal care and
use committee of Tongji Medical College, Huazhong
University of Science andTechnology and theUniversity of
California at Davis (approval numbers 17407 and 19147).
Experimental animals and in vivo treatment
C57BL/6 mice were purchased from Charles River
and Beijing HFK Bioscience Co. Ltd, China. In brief,
50 wild-type (WT) and 50 β2AR global knockout
(β2AR-KO) 5- to 6-week-old male C57BL/6J mice were
randomly assigned to low-fat or high-fat diet for 8 weeks
(n = 25 each group). The diets used for these studies
were fromResearchDiets (NewBrunswick,NJ,USA),with
10% kcal fat (catalogue no. D12450J) used as the control
normal chow (NC) diet and 60% kcal fat diet (catalogue
no. D12492) used as the HFD. The mice had ad libitum
access to food and they were housed in a room with a 12 h
light–12 h dark cycle.
Intraperitoneal glucose tolerance test
Micewere fasted for 16 h and then challengedwith glucose
(1 gkg−1, I.P.). Blood samplesweredrawn fromthe tail vein
immediately before the glucose challenge and at 30, 60, 90
and 120min thereafter. Blood glucose concentrationswere
determined using a glucometer (ACCU-CHEK, Roche,
Mannheim, Germany). The area under the curve (AUC)
was calculated to evaluate glucose tolerance.
Insulin tolerance test and blood insulin detection
After a 6 h fast, mice were injected with insulin
(0.75 U kg−1, I.P.; Sigma, St Louis, MO, USA). The blood
glucose value and AUC were assessed before and at 30,
60, 90 and 120 min after injection of insulin. Blood
serum was collected before glucose injection to measure
the insulin concentration. Insulin was measured using
ALPCO mouse ultrasensitive insulin ELISA kits (Salem,
NH, USA) according to the manufacturer’s protocol.
Echocardiography
Echocardiography was performed using a Vevo 2100
imaging system from Visual Sonics (Toronto, ON,
Canada) with a 22–55 MHz MS550D transducer. Mice
were anaesthetized with isofluorane supplemented with
100% O2, and the body temperature, respiratory rate and
ECG were constantly monitored. To minimize variation
of the data, the heart rate was maintained at 400–450
beatsmin−1 during themeasurements of cardiac function.
Cardiac function was recorded at the baseline and after
administration of the βAR agonist isoproterenol (ISO,
0.2 mg kg−1, I.P.; Sigma). Systolic function parameters,
including the EF and fractional shortening (FS), were
measured by two-dimensional parasternal short-axis
imaging plane of M-mode traces close to the papillary
muscle level. Tissue Doppler imaging mode was applied
to measure diastolic function as previously described (Qi
et al. 2013; Zhang et al. 2013).
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Haemodynamic study
Haemodynamic measurement was carried out with a
pressure catheter (SPR-839;Millar Instruments, Houston,
TX, USA) connected to an AD Instruments Power-Lab
4/30 with Lab Chart Pro 7.0 software (MPVS-300; AD
Instruments, Colorado Springs, CO, USA). In brief, mice
were anaesthetized by I.P. injection of ketamine and
xylazine (80 and 5 mg kg−1, respectively, Sigma, St Louis,
MO, USA) and placed in the supine position on a heat
pad. A ventral mid-line neck incision was made, the
carotid artery separated from the vagus nerve and a
pressure–volume catheter inserted via the carotid artery
tip into the left ventricle. After 5–10 min of stabilization,
the baseline pressure was recorded. To measure the
β-adrenergic response, 0.2 mg kg−1 ISO was injected
I.P. Measurements and analysis were performed with Lab
Chart Pro 7.0.
Adult myocyte-shortening assay
Adult mouse cardiomyocytes were isolated from WT and
β2-KO mice as indicated and cultured as described pre-
viously (Soto et al. 2009). Cells were placed in the middle
of a glass-bottomed dish with beating buffer (mM: NaCl,
120; KCl, 5.4; NaH2PO4, 1.2; MgSO4, 1.2; Hepes, 20;
glucose, 5.5; and CaCl2, 1; pH 7.1) and allowed to settle
for 10min. Platinum electrodes were placed near the cells,
and the cells were paced at 1 Hz with a voltage of 30 V
using an SD9 stimulator (Grass Technology, Warwick,
RI, USA) as described by Fu et al. (2015). The contra-
ctile shortening events of myocytes were recorded on an
inverted microscope (Zeiss AX10; Dublin, CA, USA) at
×20 magnification, which allowed observation of eight
to 10 rod-shaped cardiomyocytes with clear striations per
field of view using the MetaMorph program (Molecular
Devices, Sunnyvale, CA, USA). The maximal shortening
was analysed by MetaMorph and normalized to the
baseline.
Western blot analysis
Adult cardiomyocytes isolated from NC and HFD mice
were stimulated with ISO (100 nmol l−1) after incubation
with or without pertussis toxin (1 mg ml−1 for 3 h). Left
ventricular extracts or adult cardiomyocyte lysates were
homogenized at 4°C for Western blotting using standard
methods previously described (Fu et al. 2014).Membranes
were probed with antibodies directed at β1AR (V-19,
1:500 dilution), β2AR (M-20, 1:500 dilution), GRK2
(C-15, 1:1000 dilution) and Gαi (C-10, 1:1000 dilution)
from SCBT (Santa Cruz, CA, USA), phospho-troponin I
(Ser23/24, #4004, 1:2000 dilution) and troponin I (#4002,
1:2000 dilution) fromCell Signaling (Danvers,MA, USA),
SERCA (2A7-A1, 1:1000 dilution; Thermo, Rockford, IL,
USA), phospho-phospholamban (Ser16, 1:5000 dilution;
Bradilla, London, UK), phospholamban (MA3-922,
1:1000 dilution; Affinity Bioreagent, Golden, CO, USA)
and γ-tubulin (T6557, 1:5000 dilution; Sigma-Aldrich, St
Louis, MO, USA). The primary antibodies were revealed
with fluorescent-conjugated secondary antibodies using
an Odyssey scanner (Li-COR Biosciences, Lincoln, NE,
USA). The signal was quantified by Image Studio software
version 2.1 (Li-COR Biosciences).
Histology
Mouse hearts were perfused with 4% paraformaldehyde
and fixed in paraformaldehyde for 24 h. Fixed hearts
were paraffin embedded and serially sectioned at 5 μM
on a microtome. Tissue sections were stained with
Haematoxylin and Eosin to examine heart morphology.
Masson’s trichrome staining was used to examine myo-
cardial fibrosis. The blue-stained areas in Masson’s
trichrome staining and cardiomyocyte cross-section in
Haematoxylin and Eosin stainingweremeasured using the
ImageJ program (National Institutes of Health, Bethesda,
MD, USA) by a researcher blinded to the samples. The
quantification was performed in five regions of each
heart.
Quantitative real-time PCR analysis
Total RNA was isolated from snap-frozen hearts using
RNAiso Plus (TaKaRa Bio Inc., Kusatsu, Shiga, Japan)
according to the manufacturer’s protocol. First-strand
cDNA was synthesized from RNA using a SMARTer
PCR cDNA Synthesis Kit (TaKaRa Bio Inc.). Real-time
quantitative RT-PCR was performed with a Step One
Plus Real-Time PCR system thermocycler (Thermo Fisher
Scientific, Waltham, MA, USA) using SYBR Premix Ex
Taq (Tli RNaseH Plus; TaKaRa Bio Inc.). All the primer
sequences are listed in Table 1. The relative expression
level of specificmRNAwas determined by the comparative
cycle threshold (CT)method (2−CT) normalized to end-
ogenous control GAPDH gene.
Statistical analysis
All statistical analyses were performed using GraphPad
Prism 6 software (GraphPad Software Inc., La Jolla, CA,
USA). Statistical analyses were performed using Student’s
two-tailed unpaired t test, one-way ANOVA followed
by Tukey’s post hoc test or two-way repeated-measures
ANOVA with Bonferroni multiple comparisons test. A
value of P < 0.05 was considered to indicate statistical
significance. All data are expressed as means ± SEM. The
sample size for each group is shown in the figure legends
or tables.
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 1. Quantitative RT/PCR primer sequences
Gene Primer Sequence
α-Myosin heavy chain (α-MHC) Forward 5′-CAACGCCAAGTGTTCCTC-3′
Reverse 5′-AGCTCTGACTGCGACTCCTC-3′
β-Myosin heavy chain (β-MHC) Forward 5′-ATGTGCCGGACCTTGGAAG-3′
Reverse 5′-CCTCGGGTTAGCTGAGAGATCA-3′
Atrial natriuretic peptide (ANP) Forward 5′-TCGTCTTGGCCTTTTGGCT-3′
Reverse 5′-TCCAGGTGGTCTAGCAGGTTCT-3′
Brain natriuretic peptide (BNP) Forward 5′-CTCCTGAAGGTGCTGTCC-3′
Reverse 5′-GCCATTTCCTCCGACTTT-3′
α-Smooth muscle actin (αSMA) Forward 5′-GTCCCAGACATCAGGGAGTAA-3′
Reverse 5′-TCGGATACTTCAGCGTCAGGA-3′
Connective tissue growth factor (CTGF) Forward 5′-CACAGAGTGGAGCGCCTGTTC-3′
Reverse 5′-GATGCACTTTTTGCCCTTCTTAATG-3′
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) Forward 5′-CATGGCCTTCCGTGTTCCTA-3′
Reverse 5′-CCTGCTTCACCACCTTCTTGAT-3′
Results
We fed C57BL/6J wild-type mice with 60% HFD
for 8 weeks. The HFD-fed mice exhibited significant
body weight gain compared with the mice fed with
NC, which was associated with elevated fasting blood
glucose and insulin (Fig. 1A–C). The HFD mice also
exhibited significant glucose intolerance and mild insulin
intolerance relative to NC control animals (Fig. 1D and
E). The overall features indicated a stage of prediabetes
or an early stage of diabetes associated with obesity.
At this stage, echocardiographic analysis revealed that
cardiac contractile function, including the systolic indices
of EF and FS and the diastolic parameter isovolumetric
relaxation time (IVRT), was normal in HFD animals
relative to NC control animals (Fig. 1F–H and Table 2).
Consistent with the observed cardiac function, HFD
hearts were grossly normal in morphology, with mild
hypertrophy (Fig. 2A and B). We also examined the
cardiac contractile reserve in response to β-adrenergic
stimulation, which is usually impaired in patients with
diabetes and/or metabolic syndrome (Scognamiglio et al.
1998). Despite the grossly normal cardiac structure and
function, the cardiac contractile reserve in response to
the β-adrenergic agonist isoproterenol was impaired in
HFD animals relative to NC control mice (Fig. 1F and G
and Table 2). Further examination showed that there was
no significant change in expression of regulatory proteins
in excitation–contraction coupling, including troponin I
(TnI), phospholamban (PLB) and sarco/endoplasmic
reticulum calcium ATPase 2 (SERCA2a; Fig. 2C and D).
Moreover, the basal levels of phosphorylation of PLB and
TnI by PKA, which is essential for excitation–contraction
coupling, were not altered in HFD hearts relative to
NC control hearts (Fig. 2C and D). Together, these
observations suggest that 8 weeks of HFD feeding induced
mild or early diabetes in mice, which was associated with
impaired contractile reserve to adrenergic stress despite
overall normal cardiac structure and function.
We then set out to examine potential alterations in
cardiac adrenergic signalling pathways in the HFD mice.
The HFD hearts displayed normal expression of β1AR,
β2AR and G-protein. G-Protein receptor kinase 2, a
kinase that regulates cardiac adrenergic signalling and
is usually upregulated in heart failure, was not altered
either (Fig. 3A and B). However, the β2ARs in HFD
hearts displayed increased levels of phosphorylation at
both the PKA site serine 261/262 and the GRK site
serine 355/356 relative to NC control hearts (Fig. 3C
and D). To assess adrenergic signalling directly in cardio-
myocytes, we isolated adult myocytes from NC and HFD
mice to perform a contractile shortening assay. Myo-
cytes from both NC and HFD mice exhibited similar
contractile shortening at baseline (Fig. 3E). However,
myocytes from HFD mice exhibited a reduced contra-
ctile response to isoproterenol stimulation relative to NC
control myocytes (Fig. 3E). Consistently, myocytes from
HFD mice exhibited a reduced PKA phosphorylation of
PLB at serine 16 in response to isoproterenol stimulation
relative to NC control myocytes (Fig. 3F). We have
recently shown that acute insulin stimulation promotes
β2AR coupling to Gi in cardiomyocytes (Fu et al.
2014). Inhibition of Gi with pertussis toxin increased
the isoproterenol-induced PKA phosphorylation of PLB
in cardiomyocytes from HFD mice (Fig. 3G), indicating
that isoproterenol triggered βAR activation of Gi in HFD
cardiomyocytes. As a control, pertussis toxin did not
affect isoproterenol-induced phosphorylation of PLB in
NC cardiomyocytes. Together, these data suggested that
HFD feeding promoted desensitization of cardiac βAR
via phosphorylation at both PKA and GRK sites, which
resulted in a reduced contractile shortening response to
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
1978 Q. Fu and others J Physiol 595.6
adrenergic stress in the cardiomyocytes. Consequently,
the reduced myocyte shortening is likely to contribute
to the impaired cardiac contractile reserve in response to
β-adrenergic stimulation in vivo (Fig. 1).
We then used mice lacking the β2AR gene to assess the
role of the β2AR in HFD-induced impairment of contra-
ctile reserve in hearts. After HFD feeding, β2AR-KO mice
exhibited significant body weight gain compared with the
β2AR-KO NC control mice, which was associated with
elevated resting blood glucose and insulin, similar to those
in WT mice (Fig. 4A–C). The HFD-fed β2AR-KO mice
also exhibited significant glucose intolerance and mild
insulin intolerance relative to NC control animals (Fig. 4D
and E). Overall, echocardiographic analysis revealed that
cardiac function was normal in HFD β2AR-KO mice,
including the systolic indices of EF and FS and the diastolic
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Figure 1. Feeding high-fat diet (HFD) for 8 weeks induces impairment of cardiac functional reserve in
response to adrenergic stimulation
A–C show body weight (A), fasting blood glucose (B) and fasting serum insulin concentrations (C) after 8 weeks of
normal chow (NC) or high-fat diet (HFD) feeding. ∗P < 0.05 and ∗∗P < 0.01 between HFD and NC groups (n = 10).
The HFD induces glucose intolerance (D) and mild insulin intolerance (E) when compared with NC control animals.
∗P < 0.05 and ∗∗P < 0.01 by two-way repeated-measures ANOVA with Bonferroni multiple comparisons test
(n = 5–7). F–H, cardiac contractile function of the mice before and after β-adrenergic stimulation [isoproterenol
(ISO), 0.2 mg kg−1, I.P.] was measured by echocardiography after 8 weeks of HFD. Data show ejection fraction
(F) and fractional shortening (G) measured by M-mode, and isovolumetric relaxation time (IVRT; H) measured by
tissue Doppler image mode. ∗∗P < 0.01 and ∗∗∗P < 0.001 (n = 8) by one-way ANOVA followed by Tukey’s post
hoc test.
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Table 2. Echocardiographic characteristics of NC and HFD mice treated with β-adrenergic stimulation (ISO, 0.2 mg kg−1, i.p.)
Paramter NC NC + ISO HFD HFD + ISO
HR (beats min−1) 419 ± 14.42 603 ± 9.16∗∗∗ 411 ± 21.40 617 ± 13.10∗∗∗
IVS;d (mm) 0.67 ± 0.05 0.83 ± 0.09 0.69 ± 0.06 0.81 ± 0.06
IVS;s (mm) 0.94 ± 0.10 1.39 ± 0.12∗ 1.28 ± 0.36 1.27 ± 0.12
LVID;d (mm) 3.67 ± 0.07 3.18 ± 0.08 3.64 ± 0.19 3.23 ± 0.26
LVID;s (mm) 2.53 ± 0.09 1.41 ± 0.10∗ 2.32 ± 0.26 1.69 ± 0.29
LVPW;d (mm) 0.73 ± 0.06 0.72 ± 0.07 0.79 ± 0.03 0.82 ± 0.11
LVPW;s (mm) 1.05 ± 0.06 1.17 ± 0.11 1.09 ± 0.07 1.2 ± 0.15
EF (%) 57.94 ± 2.22 88.25 ± 1.79∗∗∗ 60.54 ± 1.27 76.25 ± 2.58∗∗∗##
FS (%) 30.07 ± 1.53 57.66 ± 2.45∗∗∗ 31.81 ± 0.92 44.14 ± 6.15∗∗∗##
LV mass (mg) 88.04 ± 6.70 73.8 ± 7.06 94.91 ± 4.59 80.76 ± 6.67
LV mass (corrected) 68.84 ± 5.36 59.04 ± 5.65 75.93 ± 3.67 64.61 ± 5.33
LV Vol;d (μI) 58.43 ± 2.12 38.4 ± 3.82∗∗∗ 62.2 ± 3.46 40.91 ± 3.64∗∗∗
LV Vol;s (μI) 24.66 ± 1.80 4.38 ± 0.75∗∗∗ 24.44 ± 1.22 9.9 ± 1.73∗∗∗
Results are expressed as means ± SEM (n = 8 per group). ∗P < 0.05, ∗∗P < 0.01 and ∗∗∗P < 0.001 compared with the control group.
##P < 0.01 compared with the NC + ISO group. Abbreviations: EF, ejection fraction; FS, fractional shortening; HFD, high-fat diet; HR,
heart rate; ISO, isoproterenol; IVS;s and IVS;d, interventricular septal wall thickness at systole and diastole; LVID;s and LVID;d, left
ventricular dimension at systole and diastole; LV mass, left ventricular mass; LV mass (corrected), LV mass corrected for body surface
area LVPW;s and LVPW;d, posterior wall thickness at systole and diastole; LV Vol;s and LV Vol;d, left ventricle volume at systole and
diastole; and NC, normal chow.
parameter IVRT (Fig. 4F–H). In contrast to WT mice,
mice lacking the β2AR exhibited normal cardiac contra-
ctile reserve in response to β-adrenergic stimulation after
HFD feeding (Fig. 4F and G). There was no significant
change in expression of TnI, PLB and SERCA2a pump in
HFD β2AR-KO hearts compared with NC β2AR-KOmice
(Fig. 5A and B). The phosphorylation of TnI and PLB was
also preserved in HFD-fed β2AR-KO hearts (Fig. 5A and
B). Moreover, HFD β2AR-KO hearts exhibited normal
expression of β1AR, G-protein and GRK2 compared
with NC β2AR-KO mice (Fig. 5C and D). Consistently,
myocytes isolated from HFD β2AR-KO mice exhibited
normal contractile shortening in the resting state and after
stimulation with isoproterenol (Fig. 5E). Together, these
data indicated that deletion of β2AR gene ameliorated
HFD-induced impairment of contractile reserve in
hearts.
We also assessed cardiac function directly with
haemodynamic studies in vivo. In WT mice, 2 months of
HFD feeding did not affect contractile properties at the
baseline, including maximal dP/dt (maximum values of
the first derivative of left ventricular pressure 7789± 699.9
vs. 7078 ± 748.5 mmHg s−1), minimal dP/dt (minimum
values of the first derivative of left ventricular pressure
−5962± 640.3 vs.−5502± 461.5mmHg s−1) and cardiac
output (6380 ± 758.3 vs. 5078 ± 1164 μl min−1), but
significantly impaired cardiac contractility in response to
administration of isoproterenol, includingmaximal dP/dt
(16,973 ± 506.9 vs. 14,472 ± 432.8 mmHg s−1), minimal
dP/dt (−10,466 ± 673.6 vs. −8710 ± 673.6 mmHg s−1)
and cardiac output (16,648 ± 668.2 vs.
12,203 ± 1548 μl min−1; Fig. 6A–D). In comparison,
deletion of β2AR normalized cardiac contractility in
HFD mice, including maximal dP/dt (8196 ± 724.3
vs. 10,504 ± 1212 mmHg s−1), minimal dP/dt
(−6910 ± 613.4 vs. −8808 ± 978.5 mmHg s−1) and
cardiac output (7274 ± 1502 vs. 9733 ± 1721 μl min−1),
and rescued cardiac contractile reserve in response
to administration of isoproterenol, including
maximal dP/dt (20,046 ± 746.7 vs. 20,576 ± 792.8
mmHg s−1), minimal dP/dt (−11,339 ± 769.9 vs
−12,053 ± 1170 mmHg s−1) and cardiac output
(19,388 ± 2871 vs. 16,719 ± 2161 μl min−1; Fig. 6A–D).
Discussion
β-Adrenergic receptors are the key regulators of cardiac
function in response to stress. In heart diseases, βARs
are often desensitized via phosphorylation as a result
of elevated sympathetic drive (Brum et al. 2006). Here,
we show that 2 months of HFD feeding promotes
phosphorylation of cardiac β2ARs at both PKA and GRK
sites, attenuationofmyocyte contractile shortening in vitro
and impairment of cardiac contractile reserve in vivo in
response to adrenergic stimulation. The HFD-induced
attenuation of the adrenergic response occurs without
significant alteration of the cardiac structure and basal
function.These data providedirect evidence that 2months
of HFD feeding promotes phosphorylation of β2ARs,
which is correlated with the compromised cardiac stress
response that is present in HFD-fedmice before structural
remodelling occurs in hearts.
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Figure 2. Mice after 8 weeks of HFD feeding display normal cardiac gene expression and morphology
A, heart sections from NC and HFD mice were stained with Haematoxylin and Eosin (HE; scale bar = 100
μm) to examine heart morphology and stained with Masson’s trichrome (scale bar = 100 μm) to examine
fibrosis. The cardiomyocyte cross-sectional areas and fibrosis-positive areas were quantified and plotted (n = 3).
B, RT-PCR showing left ventricular expression of genes involved in cardiac hypertrophy and fibrosis in mice after
8 weeks of HFD. C and D, Western blots showing protein kinase A (PKA) phosphorylation of phospholamban
(PLB) and troponin I (TnI), and SERCA2a expression in NC and HFD mouse hearts. [Colour figure can be viewed at
wileyonlinelibrary.com]
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In a classic view, during augmented circulatory
demands in clinical conditions such as diabetes mellitus,
the increased sympathetic activity and subsequent βAR
stimulation is an important physiological mechanism
to enhance cardiac performance. However, the chronic
increase of cardiac adrenergic drive could in turn
promote β1AR desensitization, internalization and/or
downregulation (Brodde et al. 2006), contributing to
the development and progression of diabetic cardio-
myopathy (Aneja et al. 2008; Tillquist & Maddox, 2012)
and heart failure (Lymperopoulos et al. 2013; Florea &
Cohn, 2014). In comparison, β2ARs are known to couple
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Figure 3. Feeding the HFD for 8 weeks induces an impaired contractility response to adrenergic
stimulation in cardiomyocytes
A and B, Western blots show the expression of cardiac β1-adrenergic receptor (β1AR), β2-adrenergic receptor
(β2AR), G-protein and G-protein receptor kinase (GRK)2 in NC and HFD hearts. C and D, Western blots show the
phosphorylation of β2AR at both PKA and GRK sites in NC and HFD hearts. ∗P < 0.05 by Student’s t test between
paired groups. E, data show contractile function in response to β-adrenergic stimulation (ISO, 100 nM) in adult
cardiac myocytes isolated from NC and HFD mice. ∗∗∗P < 0.001 by one-way ANOVA followed by post hoc Tukey’s
test. F and G, data show PKA phosphorylation of PLB in response to β adrenergic stimulation (ISO, 100 nM) in the
absence or presence of pertussis toxin (PTX, 1 μg ml−1, 3 h) in adult cardiomyocytes isolated from NC and HFD
mice (n = 3). ∗P < 0.05 by Student’s t test between paired groups.
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in HFD mice
A–C show body weight (A), fasting glucose (B) and insulin concentrations (C) in mice lacking the β2AR (β2AR-KO)
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functionally to both stimulatory G protein (Gs) and Gi
to modulate cAMP production (Grundy, 2015), and the
phosphorylation of β2AR promotes a coupling switch
from Gs to Gi (Daaka et al. 1997), which induces Akt
signalling to protectmyocytes against apoptosis (Zhu et al.
2001). However, the same β2AR–Gi coupling can lead
to inhibition of cAMP production by adenylate cyclase
and subsequent PKA activity, which has been shown to
contribute to cardiac dysfunction in pressure-overload
transaortic constriction models (Du et al. 2000; Zhu
et al. 2012). In the present study, HFD feeding
promoted phosphorylation of cardiac β2ARs at PKA
and GRK sites, decreased PKA phosphorylation of PLB
and attenuated myocyte shortening and cardiac contra-
ctile reserve in response to β-adrenergic stimulation.
Incubation with the Gi inhibitor pertussis toxin increased
isoproterenol-induced phosphorylation of PLB in iso-
lated HFD cardiomyocytes, confirming that isoproterenol
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Figure 5. Deletion of the β2AR gene normalizes myocyte contractile response to adrenergic stimulation
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Western blots show PKA phosphorylation of PLB and TnI, and SERCA2a expression (A and B), as well as expression
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triggered receptor activation ofGi to shunt theβ2AR signal
away from PKA activation. Deletion of the β2AR restored
the contractile response in cardiomyocytes isolated from
HFDmice and normalized contractile reserve in response
to adrenergic stress. Together, these data indicate thatHFD
feeding promoted both phosphorylation of β2ARs and
the receptor coupling to inhibitory G-protein to diminish
contractile reserve in the mice.
β-Adrenergic receptors are known to undergo
heterologous desensitization mediated by secondary
messenger-dependent kinases, including PKA and protein
kinase C (Chuang et al. 1996; Gainetdinov et al. 2004).
Recent studies show that a growing list of neurohormonal
factors and cytokines can promote desensitization of
cardiac βARs and contribute to cardiac dysfunction via
divergent cross-talk mechanisms in vivo (Vasudevan et al.
2013; Tilley et al. 2014). For example, tumour necrosis
factor α promotes GRK-dependent phosphorylation
of β2ARs, which attenuates adrenergic signalling and
exacerbates cardiac dysfunction in a pressure-overload
model with transaortic constriction (Vasudevan et al.
2013). Block of tumour necrosis factor α signalling
ameliorates cardiac dysfunction in mice. Interestingly,
tumour necrosis factor α induces GRK2-mediated
desensitization of βARs in a Gβγ-independent fashion.
Coincidentally, insulin also promotes a Gβγ-independent
GRK2 phosphorylation of β2AR in the heart, which is
dependent on IR and insulin receptor substrates (Daaka
et al. 1997; Fu et al. 2014). These observations suggest that
GRK2 functions as a key factor to promote desensitization
of cardiac βARs independent of sympathetic drive. As
a result, tumour necrosis factor α and insulin are
linked to cardiac adrenergic regulation by promoting
βAR phosphorylation and/or desensitization, which can
either directly induce cardiac dysfunction or exacerbate
cardiac pathophysiology in heart failure. Notably, recent
clinical trials of diabetic medications (e.g. glyburide) in
heart failure patients show adverse effects (Basu et al.
2007; Pantalone et al. 2012), suggesting that aggressive
metabolic controls with insulin secretagogues might
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Figure 6. Deletion of the β2AR gene normalizes the cardiac functional reserve response to adrenergic
stimulation after HFD feeding
After HFD feeding, cardiac haemodynamics were measured in wild-type (WT) and β2AR-KO mice before and after
I.P. injection of ISO (0.2 mg kg−1). The maximal dP/dt (A), minimal −dP/dt (B), cardiac output (C) and heart rate (D)
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exacerbate cardiac symptoms. This may be attributable to
these medications driving IR-mediated phosphorylation
of β2AR. On the other hand, a hyperinsulinaemia-driven
phosphorylation of β2ARs might offer an explanation for
the lack of benefit from β-blocker therapy in heart failure
patientswith diabetesmellitus (Haas et al. 2003). Together,
these studies suggest the therapeutic potential of targeting
hyperinsulinaemia and the Gβγ-independent GRK2
signallingpathway inheart failure associatedwithdiabetes.
In summary, we show that cardiac β-adrenergic
signalling is impaired in the early stages of diabetes after
8 weeks of HFD feeding, which occurs before structural
change in the heart. This study also suggests that clinical
intervention might be applied to subjects with early
diabetes without cardiac symptoms to prevent further
cardiac complications.
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